Next-generation tissue-engineered heart valves with repair, remodelling and regeneration capacity
ES Fioretta, SE Motta, V Lintas, S Loerakker… - Nature Reviews …, 2021 - nature.com
Valvular heart disease is a major cause of morbidity and mortality worldwide. Surgical valve
repair or replacement has been the standard of care for patients with valvular heart disease …
repair or replacement has been the standard of care for patients with valvular heart disease …
Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at intermediate risk: results from the PARTNER 2 …
SJ Baron, K Wang, JA House, EA Magnuson… - Circulation, 2019 - Am Heart Assoc
Background: In patients with severe aortic stenosis (AS) at intermediate surgical risk,
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …
treatment with transcatheter aortic valve replacement (TAVR) or surgical aortic valve …
[HTML][HTML] Transcatheter versus surgical aortic valve replacement in low and intermediate risk patients with severe aortic stenosis: systematic review and meta-analysis …
J Fu, MS Popal, Y Li, G Li, Y Qi, F Fang… - Journal of Thoracic …, 2019 - ncbi.nlm.nih.gov
Background To compare the outcome of transcatheter aortic valve replacement (TAVR) with
surgical aortic valve replacement (SAVR) in low and intermediate risk patients with severe …
surgical aortic valve replacement (SAVR) in low and intermediate risk patients with severe …
The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis
Aims The economic value of transcatheter aortic valve replacement (TAVR) in low surgical
risk patients with severe, symptomatic aortic stenosis is not known. Our objective was to …
risk patients with severe, symptomatic aortic stenosis is not known. Our objective was to …
Cost-effectiveness of transcatheter versus surgical aortic valve replacement in low-risk patients with severe aortic stenosis
Background Recent studies have shown that transcatheter aortic valve implantation (TAVI) is
non-inferior to surgical aortic valve replacement (SAVR) for treatment of low-risk patients …
non-inferior to surgical aortic valve replacement (SAVR) for treatment of low-risk patients …
Cost-effectiveness analysis of the SAPIEN 3 TAVI valve compared with surgery in intermediate-risk patients
G Goodall, M Lamotte, M Ramos… - Journal of Medical …, 2019 - Taylor & Francis
Objective: Transcatheter aortic valve implantation (TAVI) has become the therapy of choice
for treating severe aortic stenosis in patients at high-risk for surgery or where it is considered …
for treating severe aortic stenosis in patients at high-risk for surgery or where it is considered …
Relative costs of surgical and transcatheter aortic valve replacement and medical therapy
AM Goldsweig, HJ Tak, LW Chen… - Circulation …, 2020 - Am Heart Assoc
Background: The number of patients treated for aortic valve disease in the United States is
increasing rapidly. Transcatheter aortic valve replacement (TAVR) is supplanting surgical …
increasing rapidly. Transcatheter aortic valve replacement (TAVR) is supplanting surgical …
Cost-effectiveness of self-expandable transcatheter aortic valves in intermediate-risk patients
DY Tam, A Hughes, HC Wijeysundera… - The Annals of thoracic …, 2018 - Elsevier
Background A recent clinical trial showed that self-expandable transcatheter aortic valve
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …
replacement (TAVR) was non-inferior to surgical aortic valve replacement (SAVR). However …
A Canadian cost-effectiveness analysis of SAPIEN 3 transcatheter aortic valve implantation compared with surgery, in intermediate and high-risk severe aortic …
JE Tarride, T Luong, G Goodall, N Burke… - ClinicoEconomics …, 2019 - Taylor & Francis
Background and objectives: The treatment of severe aortic stenosis requires replacement of
the defective native valve. Traditionally, this has been done via surgery, but in the last 10 …
the defective native valve. Traditionally, this has been done via surgery, but in the last 10 …
The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups
V Lorenzoni, G Barbieri, F Saia, F Meucci… - The European Journal of …, 2021 - Springer
Objectives To assess the cost-effectiveness (CE) of transcatheter aortic valve implantation
(TAVI) in Italy, considering patient groups with different surgical risk. Methods A Markov …
(TAVI) in Italy, considering patient groups with different surgical risk. Methods A Markov …